4.6 Review

Medical treatment of dystonia

Journal

MOVEMENT DISORDERS
Volume 28, Issue 7, Pages 1001-1012

Publisher

WILEY
DOI: 10.1002/mds.25552

Keywords

dystonia; botulinum toxin; baclofen; trihexyphenidyl; tetrabenazine

Funding

  1. Allergan, Inc.
  2. Ipsen Limited
  3. Merz Pharmaceuticals

Ask authors/readers for more resources

Medications such as anticholinergic drugs, dopamine modulators, baclofen, muscle relaxants, and other pharmacologic agents have been used for a long time to treat dystonia, but the introduction of botulinum toxin and deep brain stimulation clearly revolutionized the symptomatic treatment of this neurological movement disorder. Therapy of dystonia can be divided into the following categories: (1) physical, supportive, and ancillary therapy; (2) pharmacologic treatment; (3) chemodenervation with botulinum toxin; and (4) peripheral and central surgery (deep brain stimulation). Except in some cases of secondary dystonia, pathogenesis-targeted or disease-modifying therapy is currently not available. This review focuses on evidence-based medical treatment of dystonia, highlighting recent advances, with emphasis on individualized approach. (C) 2013 Movement Disorder Society

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available